Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

St. Jude Announces First Implant In Trial Evaluating AMPLATZER Cardiac Plug

Medical device company St. Jude Medical Inc. (STJ: Quote) Friday announced the first patient implant in a new trial evaluating the company's AMPLATZER Cardiac Plug or ACP for the prevention of stroke. The company said the AMPLATZER Cardiac Plug Clinical Trial is designed to determine the safety and effectiveness of the ACP device in preventing blood clots from migrating out of the left atrial appendage in patients with non-valvular atrial fibrillation who have a high risk for stroke.

The implant was performed by Dr. Christian Machado, director of electrophysiology at the Providence Hospital Heart Institute, Southfield, Michigan, and investigator in the study.

Explaining the need for the trial, Dr. James Hermiller, an interventional cardiologist from St. Vincent Hospital in Indianapolis and ACP Trial investigator said, "The current standard of care for the prevention of stroke is warfarin or other oral blood-thinning medications that can be difficult for some people to tolerate, and may carry a risk of serious complications, such as bleeding.."

Commenting on the development, Frank Callaghan, president of the St. Jude Medical Cardiovascular and Ablation Technologies Division said, "The AMPLATZER Cardiac Plug has shown great promise in international markets and we look forward to establishing the evidence required to make it available in the U.S."

Register
To receive FREE breaking news email alerts for St. Jude Medical Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Before heading to New York for meetings with other world leaders at the United Nations, President Barack Obama delivered a statement on Tuesday regarding U.S. airstrikes in Syria. Obama highlighted the fact that the U.S. was joined in the attack by Saudi Arabia, the United Arab Emirates, Jordan, Bahrain, and Qatar. After recovering from an initial move to the downside, stocks have shown a lack of direction over the course of the trading day on Tuesday. The choppy trading comes on the heels of the notable pullback seen in the previous session. With lawmakers failing to address corporate tax reform before adjourning for the campaign season, the Treasury Department announced Monday that it is taking targeted action to reduce the tax benefits of corporate tax inversions.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.